Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRC | P12931 | 3/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | ACP1 | P24666 | 5/20 | 0.38 |
| ▸ | PTPN12 | Q05209 | 3/20 | 0.38 |
| ▸ | PTPN7 | P35236 | 2/20 | 0.38 |
| ▸ | PTPN13 | Q12923 | 2/20 | 0.38 |
| ▸ | SSU72 | Q9NP77 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | GMNN | O75496 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL707060 | 0.79 | SRC (0.43) | SRCALDH1A1ACP1PTPN12PTPN7 | |
| SCHEMBL28031021 | 0.74 | SRC (0.59) | SRCALDH1A1ACP1PTPN12PTPN7 | |
| SCHEMBL669211 | 0.74 | SRC (0.54) | SRCALDH1A1ACP1PTPN12PTPN7 | |
| SCHEMBL6491098 | 0.70 | SRC (0.52) | SRCLMNATDP1CYP2C19CYP2D6 | |
| SCHEMBL7453634 | 0.70 | SRC (0.52) | SRCLMNATDP1CYP2C19CYP2D6 | |
| SCHEMBL626719 | 0.70 | SRC (0.54) | SRCALDH1A1LMNAKDM4EGMNN | |
| SCHEMBL915178 | 0.69 | DPP4 (0.47) | SRCLMNATSHRCYP2D6MAPK1 | |
| SCHEMBL2127256 | 0.69 | SRC (0.48) | SRCALDH1A1ACP1PTPN12PTPN7 | |
| SCHEMBL88528 | 0.69 | SRC (0.48) | SRCALDH1A1LMNAKDM4EGMNN | |
| SCHEMBL20856865 | 0.69 | ALDH1A1 (0.56) | SRCALDH1A1ACP1PTPN12PTPN7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8124793-B2 | Derivatives of ethylene methanedisulfonate as cancer chemotherapeutic agents | CRONYN MARSHALL W (US) | 2012-02-28 | — | — | US | disclosed |
| US-20090176805-A1 | DERIVATIVES OF ETHYLENE METHANEDISULFONATE AS CANCER CHEMOTHERAPEUTIC AGENTS | CRONYN MARSHALL W | 2009-07-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090176805-A1 | DERIVATIVES OF ETHYLENE METHANEDISULFONATE AS CANCER CHEMOTHERAPEUTIC AGENTS | MGMT, ETV6, EI24 | SRC 1622/4885ALDH1A1 2643/4885ACP1 1552/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.